BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9225076)

  • 1. Achievement of a complete cytogenetic response with hydroxyurea in a patient with chronic myelogenous leukemia.
    Tanaka M; Yamazaki Y; Kondo E; Hattori M; Tsushita K; Utsumi M
    Leuk Res; 1997 May; 21(5):465-8. PubMed ID: 9225076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a complex translocation [t(4;9;22)(p16;q34;q11)] in chronic myelogenous leukemia by fluorescence in situ hybridization technique.
    Gudi R; Elizalde A; Gogineni SK; Macera MJ; Badillo A; Verma RS
    Cancer Genet Cytogenet; 1996 Sep; 90(2):142-5. PubMed ID: 8830724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
    Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia.
    Amiel A; Yarkoni S; Fejgin M; Gaber E; Nagler A; Manor Y; Lishner M
    Cancer Genet Cytogenet; 1993 Jan; 65(1):32-4. PubMed ID: 8431913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
    Itoh T; Tamura S; Takemoto Y; Kakishita E
    Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An uncommon case of chronic myeloid leukemia with variant cytogenetic.
    Abdullah MA; Amer A; Nawaz Z; Abdullah AS; Al-Sabbagh A; Kohla S; Nashwan AJ; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):28-32. PubMed ID: 29633730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel variant Ph translocation t(9;22;11)(q34;q11.2;p15)inv(9)(p13q34) in chronic myeloid leukemia involving a one-step mechanism.
    Belli C; Alú MF; Alfonso G; Bianchini M; Larripa I
    Cytogenet Genome Res; 2011; 132(4):304-8. PubMed ID: 21212648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission.
    Sun J; Yin CC; Cui W; Chen SS; Medeiros LJ; Lu G
    Am J Clin Pathol; 2011 Mar; 135(3):391-7. PubMed ID: 21350093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Philadelphia chromosome positive CML patient with a unique translocation studied via GTG-banding and fluorescence in situ hybridization.
    Young C; Di Benedetto J; Glasser L; Mark HF
    Cancer Genet Cytogenet; 1996 Jul; 89(2):157-62. PubMed ID: 8697424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
    Cesar JM; Cabello P; Ferro T; Navarro JL
    Cancer Genet Cytogenet; 2006 May; 167(1):74-7. PubMed ID: 16682291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid blast crisis during complete cytogenetic remission following interferon-alpha and hydroxyurea therapy.
    Bose S; Chowdhry VP; Saxena R; Kucheria K
    Acta Haematol; 1997; 98(3):155-9. PubMed ID: 9352747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation.
    Chomel JC; Brizard F; Veinstein A; Rivet J; Sadoun A; Kitzis A; Guilhot F; Brizard A
    Blood; 2000 Jan; 95(2):404-8. PubMed ID: 10627442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
    Mohr B; Bornhäuser M; Platzbecker U; Freiberg-Richter J; Naumann R; Prange-Krex G; Mohm J; Kroschinsky F; Ehninger G; Thiede C
    Cancer Genet Cytogenet; 2001 Jun; 127(2):111-7. PubMed ID: 11425449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of Philadelphia positive chronic myelogenous leukemia associated with t(3;21) after bone marrow transplantation.
    Uriarte MR; Mori MA; de Bellis R; Cardoso H
    Cancer Genet Cytogenet; 1993 Jul; 68(2):122-5. PubMed ID: 8353803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique, complex variant philadelphia chromosome translocation in a patient with typical chronic myelogenous leukemia.
    Oudat R; Khan Z; Glassman AB
    Arch Pathol Lab Med; 2001 Mar; 125(3):437-9. PubMed ID: 11231500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.